Impeto Medical

What Impeto Medical does

Impeto Medical is a French medical device company, headquartered in Issy Les Moulineaux near Paris with a US subsidiary (SUDOSCAN Inc.) in San Diego, founded in June 2005 and acquired by Withings in 2023. It develops, manufactures, and sells the SUDOSCAN Class IIa medical device, which uses patented electrochemical skin conductance (ESC) measurement via stainless-steel electrodes to assess sudomotor (sweat gland) function as a biomarker for autonomic and small fiber neuropathy. Results are produced in under three minutes without fasting or patient preparation, and the platform is reinforced by a complementary EZSCAN diabetes risk screening device, a Sudocloud remote patient monitoring (RPM) cloud platform, and patented replacement Smart Electrodes.

The business model is hardware-led but increasingly multi-stream: device sales to hospitals, clinics, physician practices, and pharmacies under quote-based multi-year contracts; a recurring replacement-electrode consumable stream; and subscription-based cloud services (Sudocloud RPM plus SDK/HUB/API offerings targeting healthcare-data clients with a 99.9% uptime SLA). Revenue is generated globally, with direct enterprise field sales in core markets supplemented by authorized distributors across 34 countries, and a Shopify-powered US storefront for direct purchases. Customers span diabetes care (primary), neurology, oncology (chemotherapy-induced polyneuropathy), and nephrology, supported by 150 peer-reviewed publications and reference-test recognition in Germany, the EU TTR-FAP Amyloidosis Network, and the Latin America Diabetes Association.

Name

Impeto Medical

Legal name

Impeto Medical

Website

https://sudoscan.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Impeto Medical, a Paris-based medical device company acquired by Withings in 2023, manufactures and sells the SUDOSCAN Class IIa device, which uses electrochemical skin conductance to provide three-minute, non-invasive detection of autonomic and small fiber neuropathy for hospitals, clinics, and physicians across 34 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Medical Device Sales: Sale of SUDOSCAN and EZSCAN medical devices to healthcare providers including hospitals, clinics, physicians, and pharmacies worldwide. Devices are Class IIa medical devices with CE marking and FDA clearance.
2. Cloud Services (Sudocloud RPM): Remote patient monitoring cloud platform providing secure data connectivity, retrieval, and management. Subscription-based services for healthcare professionals.
3. Replacement Smart Electrodes: Sale of replacement parts and accessories for SUDOSCAN devices.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Impeto Medical develops, manufactures, and sells the SUDOSCAN medical device, a Class IIa CE-marked and FDA-cleared system that uses patented electrochemical skin conductance (ESC) measurement with stainless steel electrodes to non-invasively assess sweat gland function for early detection and longitudinal follow-up of autonomic and small fiber neuropathy. The portfolio also includes the EZSCAN device for objective diabetes risk screening and the Sudocloud remote patient monitoring cloud platform, sold to hospitals, clinics, physicians, and pharmacies across 34 countries.

Product overview

Impeto Medical offers a portfolio of medical devices focused on sudomotor function assessment for neuropathy detection. The core offerings include SUDOSCAN (class IIa medical device for early detection and follow-up of autonomic and small fiber neuropathy through electrochemical skin conductance measurement), EZSCAN (diabetes risk screening device using non-invasive sudomotor function assessment), and Sudocloud (cloud-based remote patient monitoring platform for patient data management). The product line also includes Smart Electrodes as replacement accessories and approved cleaning products for device maintenance.

Differentiator

Problem solved

Functional benefit

Brands

• SUDOSCAN: Medical device for early detection and follow-up of Autonomic and Small Fiber Neuropathy using sudomotor function assessment
• EZSCAN
• Sudocloud RPM

Products and services

• SUDOSCAN A Class IIa medical device consisting of a computer and four stainless steel electrodes on which patients place their hands and bare feet; it applies low-voltage stimulation to sweat glands and measures electrochemical skin conductance (ESC) to assess small C-fiber nerve function, delivering quantitative results in under 3 minutes for healthcare professionals managing diabetic neuropathy, small fiber neuropathies, chemotherapy-induced polyneuropathy, and autonomic dysfunction.
• EZSCAN Objective diabetes risk screening device using non-invasive assessment of sudomotor function through an Ezscan score, enabling early identification of patients at risk of diabetes via sweat gland electrochemical analysis.
• Sudocloud RPM Cloud-based remote patient monitoring platform offering secure connectivity, retrieval, and management of patient data from SUDOSCAN devices for healthcare professionals; available with SDK, HUB, and API services.
• Smart Electrodes Patented replacement electrodes for the SUDOSCAN device (US Designs D815746 and D796681; European Designs EU0028464100001S and EU0028464100002S).
• Approved Cleaning Products Manufacturer-approved low-detergent cleaning products for non-invasive medical devices, including Nosocomia Surf+PAE, Surfa'Safe Premium, Optim 33TB, and Kimtech Science Kimwipes.

Quantifiable outcome

• Results in under 3 minutes with automatic display of electrochemical skin conductance scores
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered major, core and supporting.

• WithingsmajorOthersWithings acquired Impeto Medical, integrating SUDOSCAN into the Withings health technology portfolio. This acquisition provides Impeto Medical with greater resources and distribution capabilities within the connected health device market.
• Google Cloud PlatformcoreTechnology or IntegrationPrimary data hosting infrastructure for US applications via Google Cloud Platform servers in Ashburn, Virginia. Data backups stored across multiple regions including Poland, Finland, Spain, Belgium, Germany, Netherlands, Italy, France, US-West Dalles Oregon, and North California.
• BSO (European Cloud)coreTechnology or IntegrationEuropean cloud hosting for patient-facing applications with servers in Saint Denis, France and Pantin, France. Complements Google Cloud for regional data hosting requirements.
• ShopifysupportingTechnology or IntegrationE-commerce platform powering the US SUDOSCAN store (us.sudoscan.com), enabling direct customer purchases and order management.
• SGS BelgiumcoreOthersNotified Body 1639 providing CE certification services under European Medical Device Directive 93/42 and ISO 13485:2016 quality management certification.
• International DistributorscoreChannel Partner/ Reseller/ DistributorNetwork of authorized distributors in 34 countries handling local sales, distribution, and support for SUDOSCAN products.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Masimo: Masimo is a patient-monitoring and sensor-based measurement incumbent that competes in the same clinical channels (hospitals, ICUs, outpatient clinics) where SUDOSCAN is deployed, with broader measurement portfolios.
• Abbott Diabetes Care: Abbott's Diabetes Care division (FreeStyle Libre CGM) sits in the broader diabetes management ecosystem where SUDOSCAN operates as a complementary neuropathy screening tool for endocrinologists managing diabetic patients.
• Compumedics: Compumedics is a broader neurodiagnostic and sleep-diagnostics equipment vendor with overlapping neurology-channel customers who evaluate neuropathy and autonomic function testing solutions.
• Dexcom: Dexcom is the leading continuous glucose monitor vendor and shares the same endocrinology and primary care channels where diabetic neuropathy screening (SUDOSCAN's core use case) is prescribed and reimbursed.
• Natus Medical: Natus provides a broad neurodiagnostic equipment portfolio including EMG, nerve conduction, and intraoperative monitoring — overlapping with SUDOSCAN's neuropathy diagnosis category but serving a wider neurology workflow with established incumbency.

Others

• Withings: Withings is the corporate parent of Impeto Medical since 2023 and operates connected health devices (smart scales, blood pressure monitors, sleep mats) — an enabling platform that now distributes and contextualizes SUDOSCAN within a broader consumer health ecosystem.

Direct peers

• NeuroMetrix: NeuroMetrix markets DPNCheck, a point-of-care device for detecting diabetic peripheral neuropathy — the most direct head-to-head competitor to SUDOSCAN, addressing the same diabetic neuropathy screening use case in physician offices.
• Cadwell Industries: Cadwell manufactures EMG, nerve conduction, and intraoperative neuromonitoring systems used by neurologists for peripheral neuropathy workups — competing for the same clinical diagnostic slot in neurology practices.
• Medoc: Medoc manufactures quantitative sensory testing (QST) systems such as the TSA II for small fiber and large fiber neuropathy assessment — competing with SUDOSCAN for the same small fiber neuropathy diagnostic workflow in neurology clinics.

Emerging players

• iHealth Labs: iHealth (Andon Health) is a connected health device maker whose consumer-grade diabetes and vital signs monitors occupy adjacent shelf space in pharmacies and clinics, sharing SUDOSCAN's pharmacy point-of-care distribution motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@impetomedical17
• LinkedInlinkedin.com/company/impeto-medical-sas
• Xx.com/Impeto_Medical
• Facebookfacebook.com/impetomedical

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Impeto Medical